Sri Lanka Begins Cervical Cancer Vaccination Campaign With GSK Drug
This article was originally published in PharmAsia News
Executive Summary
Sri Lanka health authorities have begun a national vaccination campaign against cervical cancer, using GlaxoSmithKline's Cervaris